Lead Discovery Center GmbH:製薬・医療:M&Aディール及び事業提携情報

◆英語タイトル:Lead Discovery Center GmbH - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA904C10623
◆発行会社(調査会社):GlobalData
◆発行日:2018年11月
◆ページ数:41
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:ドイツ
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Lead Discovery Center GmbH (LDC), a subsidiary of Max Planck Innovation GmbH is a biomedical research company that offers development of novel drugs and therapies. The company develops drugs and therapies for diseases such as neurodegenerative cardiovascular diseases, cancer, inflammatory disorders, inflammatory disorders and infections, metabolic syndrome, and unmet clinical needs. It offers services such as medical chemistry through organic synthesis, design of focused compound libraries, establishment of structure-activity, computer-aided rational drug design, and structure-property relationships, among others. LDC offers services through its departments including assay development and screening, medicinal chemistry, biology and pharmacology. The company collaborates with universities and academic research institutions for professional drug discovery support. LDC is headquartered in Dortmund, Germany.

Lead Discovery Center GmbH – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Lead Discovery Center GmbH, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Lead Discovery Center GmbH, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Lead Discovery Center GmbH, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Lead Discovery Center GmbH, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Lead Discovery Center GmbH, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
Lead Discovery Center GmbH, Pharmaceuticals & Healthcare, Deal Details 12
Venture Financing 12
UGISense Raises Funds through Financing 12
UGISense to Raise USD1.3 Million Venture Financing 13
Partnerships 14
APEIRON Biologics Enters into Agreement with Lead Discovery Center 14
Grunenthal, Lead Discovery Center, Max-Planck Innovation and Max Planck Institute of Experimental Medicine Enter into Agreement 15
Daiichi Sankyo, Max Planck Innovation and Lead Discovery Center Enter into Research Agreement 16
Arix Bioscience, Lead Discovery Center, Max Planck Innovation and University of Leeds Enter into Partnership 17
Lead Discovery Center to Enter into Development Agreement with UGISense 18
Lead Discovery Center Enters into Research Agreement with McGill University 19
LDC, Max Planck Innovation Enters into Agreement with Boehringer Ingelheim 20
Lead Discovery Center to Enter into Drug Discovery Agreement with Roche 21
Lead Discovery Center Partners with Infinity Pharma 22
Johnson & Johnson Innovation Partners with Lead Discovery Center 23
Qurient Enters into Agreement with Lead Discovery Center 24
AstraZeneca Expands Drug Discovery Agreement with Lead Discovery Center 25
Lead Discovery Center Enters into Research Agreement with Helmholtz Center 26
Lead Discovery Center Enters into Agreement with UiT The Arctic University of Norway 27
Lead Discovery Center Partners with Helmholtz Association of German Research Centres 28
Daiichi Sankyo Enters Into Drug Discovery Agreement With Lead Discovery Center 29
Lead Discovery Center, Centre for Drug Design and Discovery and Axxam Form Joint Venture 30
Merck Serono Enters Into Discovery Agreement With Lead Discovery Center 31
AstraZeneca Enters Into Drug Discovery Agreement With Lead Discovery Center 32
Licensing Agreements 33
Sotio Enters into Licensing Agreement with Lead Discovery Center 33
Lead Discovery Center Enters into Licensing Agreement with Qurient 34
Qurient Enters Into Licensing Agreement with Max Planck Society and Lead Discovery Center 35
Max Planck Institute of Biochemistry And Lead Discovery Center Enter Into Licensing Agreement With Qurient For Kinase Inhibitor 36
Lead Discovery Center GmbH – Key Competitors 38
Lead Discovery Center GmbH – Key Employees 39
Lead Discovery Center GmbH – Locations And Subsidiaries 40
Head Office 40
Other Locations & Subsidiaries 40
Joint Venture 40
Appendix 41
Methodology 41
About GlobalData 41
Contact Us 41
Disclaimer 41

List of Tables
Lead Discovery Center GmbH, Pharmaceuticals & Healthcare, Key Facts 2
Lead Discovery Center GmbH, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Lead Discovery Center GmbH, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Lead Discovery Center GmbH, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Lead Discovery Center GmbH, Deals By Therapy Area, 2012 to YTD 2018 8
Lead Discovery Center GmbH, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
UGISense Raises Funds through Financing 12
UGISense to Raise USD1.3 Million Venture Financing 13
APEIRON Biologics Enters into Agreement with Lead Discovery Center 14
Grunenthal, Lead Discovery Center, Max-Planck Innovation and Max Planck Institute of Experimental Medicine Enter into Agreement 15
Daiichi Sankyo, Max Planck Innovation and Lead Discovery Center Enter into Research Agreement 16
Arix Bioscience, Lead Discovery Center, Max Planck Innovation and University of Leeds Enter into Partnership 17
Lead Discovery Center to Enter into Development Agreement with UGISense 18
Lead Discovery Center Enters into Research Agreement with McGill University 19
LDC, Max Planck Innovation Enters into Agreement with Boehringer Ingelheim 20
Lead Discovery Center to Enter into Drug Discovery Agreement with Roche 21
Lead Discovery Center Partners with Infinity Pharma 22
Johnson & Johnson Innovation Partners with Lead Discovery Center 23
Qurient Enters into Agreement with Lead Discovery Center 24
AstraZeneca Expands Drug Discovery Agreement with Lead Discovery Center 25
Lead Discovery Center Enters into Research Agreement with Helmholtz Center 26
Lead Discovery Center Enters into Agreement with UiT The Arctic University of Norway 27
Lead Discovery Center Partners with Helmholtz Association of German Research Centres 28
Daiichi Sankyo Enters Into Drug Discovery Agreement With Lead Discovery Center 29
Lead Discovery Center, Centre for Drug Design and Discovery and Axxam Form Joint Venture 30
Merck Serono Enters Into Discovery Agreement With Lead Discovery Center 31
AstraZeneca Enters Into Drug Discovery Agreement With Lead Discovery Center 32
Sotio Enters into Licensing Agreement with Lead Discovery Center 33
Lead Discovery Center Enters into Licensing Agreement with Qurient 34
Qurient Enters Into Licensing Agreement with Max Planck Society and Lead Discovery Center 35
Max Planck Institute of Biochemistry And Lead Discovery Center Enter Into Licensing Agreement With Qurient For Kinase Inhibitor 36
Lead Discovery Center GmbH, Key Competitors 38
Lead Discovery Center GmbH, Key Employees 39
Lead Discovery Center GmbH, Subsidiaries 40
Lead Discovery Center GmbH, Joint Venture 40

List of Figures
Lead Discovery Center GmbH, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
Lead Discovery Center GmbH, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
Lead Discovery Center GmbH, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
Lead Discovery Center GmbH, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
Lead Discovery Center GmbH, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Lead Discovery Center GmbH, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
Lead Discovery Center GmbH, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Lead Discovery Center GmbH, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8

★海外企業調査レポート[Lead Discovery Center GmbH:製薬・医療:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Avantec Vascular Corp:製品パイプライン分析
    Summary Avantec Vascular Corp (Avantec Vascular), a subsidiary of Goodman Co Ltd is a medical device company that develops cardiovascular interventional and peripheral vascular devices. The company's products comprise balloon catheter, aspiration catheter, device delivery system, micro catheter, gui …
  • BioStar Pharmaceuticals Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary BioStar Pharmaceuticals Inc (BioStar) is a developer, manufacturer and marketer of pharmaceutical and healthcare supplement products for various diseases and conditions. The company offers products such as huangyangning tablets, hyperthyroidism capsules, danshen granule, aoxing oleanolic aci …
  • Equifax Inc.:企業の戦略・SWOT・財務分析
    Equifax Inc. - Strategy, SWOT and Corporate Finance Report Summary Equifax Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate a …
  • Yokohama City University-製薬・医療分野:企業M&A・提携分析
    Summary Yokohama City University (YCU) is an educational university that provides various undergraduate and graduate courses. The institute offers graduate program in various courses such as international management, nanobioscience, medical life science and medicine. It conducts research that contri …
  • Taylor Communications Inc:企業の戦略的SWOT分析
    Taylor Communications Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products …
  • Daito Trust Construction Co., Ltd.
    Daito Trust Construction Co., Ltd. - Strategy, SWOT and Corporate Finance Report Summary Daito Trust Construction Co., Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, p …
  • Beaver Aerospace & Defense, Inc.:企業の戦略・SWOT・財務情報
    Beaver Aerospace & Defense, Inc. - Strategy, SWOT and Corporate Finance Report Summary Beaver Aerospace & Defense, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, produ …
  • RBC Bearings Inc (ROLL):企業の財務・戦略的SWOT分析
    Summary RBC Bearings Inc (RBC Bearings) is an industrial equipment company that manufactures and markets engineered precision bearings and products. The company offers products through industrial and aerospace division. Its industrial products include ball bearings, cam followers, collets and toolho …
  • Sage Therapeutics Inc (SAGE):企業の財務・戦略的SWOT分析
    Sage Therapeutics Inc (SAGE) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknes …
  • Service Corporation International (SCI):企業の財務・戦略的SWOT分析
    Service Corporation International (SCI) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths …
  • Boston Scientific Corp (BSX):企業の財務・戦略的SWOT分析
    Boston Scientific Corp (BSX) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknes …
  • Major Drilling Group International Inc (MDI):企業の財務・戦略的SWOT分析
    Major Drilling Group International Inc (MDI) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key stren …
  • Broadridge Financial Solutions, Inc. (BR):企業の財務・戦略的SWOT分析
    Broadridge Financial Solutions, Inc. (BR) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strength …
  • Alliance MMA, Inc. (AMMA):企業の財務・戦略的SWOT分析
    Alliance MMA, Inc. (AMMA) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses …
  • AMW GmbH:製薬・医療:M&Aディール及び事業提携情報
    Summary AMW GmbH (AMW) is a pharmaceutical company that develops and manufactures drug delivery systems for treatment in the areas of oncology, neurology, dermatology and pain. The company designs and develops novel transdermal drug delivery systems, microchip controlled patches and biodegradable su …
  • T-Mobile Netherlands Holding B.V.:企業の戦略的SWOT分析
    T-Mobile Netherlands Holding B.V. - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major p …
  • Britannia Pharmaceuticals Ltd:企業の戦略的SWOT分析
    Britannia Pharmaceuticals Ltd - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major produ …
  • Ultra Clean Holdings Inc (UCTT):企業の財務・戦略的SWOT分析
    Summary Ultra Clean Holdings Inc (UCH) is a developer and supplier of critical systems and subsystems. The company’s products include precision robotic solutions, gas delivery systems, industrial and automation production equipment, chemical delivery modules, top-plate assemblies, wafer cleaning sub …
  • S&C Electric Co:企業の戦略的SWOT分析
    S&C Electric Co - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and servic …
  • Lung Biotechnology PBC:製薬・医療:M&Aディール及び事業提携情報
    Summary Lung Biotechnology PBC (LBI), formerly Lung Biotechnology Inc, is a subsidiary of United Therapeutics Corp, is a biotechnology company that develops and commercializes new therapies for the treatment of PAH and other fatal lung diseases. The company provides product such as Adcirca and Tyvas …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆